Recipient of federal assistance · HOUSTON, TX

CELLCHORUS INC

CELLCHORUS INC received $3.1M in federal grants and other assistance in FY2026, on 9 actions, +0.8% vs FY2025. It has no federal contracts in the loaded years. Since FY2023: $8.9M. Its largest awarding agency was National Institutes of Health ($3.1M).

Assistance · FY2026
$3.1M
New awards
1
Actions
9
Since FY2023
$8.9M
UEI
LUF6ANBGK7F4
Location
HOUSTON, TX
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 599.3KFY2023
  2. 2.2MFY2024
  3. 3MFY2025
  4. 3.1MFY2026

By type

  1. Grants$3.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.350 · National Center for Advancing Translational Sciences$2.1M67%
  2. 93.859 · Biomedical Research and Research Training$998.9K33%

Awarding agencies

  1. National Institutes of Health$3.1M100%
    Department of Health and Human Services

Largest awards

  1. LF-TIMING: LARGE-SCALE LABEL-FREE PROFILING OF CELL-CELL INTERACTIONS - 7. PROJECT SUMMARY/ABSTRACT THERE IS A COMPELLING NEED FOR…$2.5M
    93.350 · National Center for Advancing Translational Sciences· National Institutes of Health· Project grant· Aug 8, 2024 – Jul 21, 2026· R42TR005299
  2. INTEGRATED ASSAYS OF SINGLE-CELL DYNAMICS AND MOLECULAR PHENOTYPE FOR CELL THERAPY MANUFACTURING - ABSTRACT CELL AND GENE THERAPIES HAVE…$2.4M
    93.350 · National Center for Advancing Translational Sciences· National Institutes of Health· Project grant· Apr 30, 2024 – Sep 2, 2026· R44TR005137
  3. DYNAMIC SINGLE-CELL ANALYSIS INSTRUMENT TO EVALUATE IMMUNE CELL FUNCTION - 7. PROJECT SUMMARY/ABSTRACT RECENT DECADES HAVE BEEN MARKED BY A…$2.3M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Apr 28, 2023 – Jul 14, 2026· R44GM149106
  4. DYNAMIC SINGLE-CELL ANALYSIS INSTRUMENT COMMERCIAL READINESS (CRP) - 7. PROJECT SUMMARY/ABSTRACT THIS PROJECT WILL SUPPORT COMMERCIALIZING…$998.9K
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 14, 2026 – Sep 14, 2026· SB1GM163323
  5. FUNCTIONAL SIGNATURES OF POST-INFUSION CAR T CELLS FOR EARLY INDICATION OF PATIENT RESPONSE - 7. PROJECT SUMMARY/ABSTRACT CHIMERIC ANTIGEN…$399.6K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Aug 21, 2025 – Jun 5, 2026· R43CA298411

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2023–FY2026.